The methylation of cg26709929 on KCNQ1 was associated with the risk of the HER-2-overexpressing subtype of BC, while the methylation of CpG with genome coordinates 2,482,233 was associated with the risk of the luminal B subtype of BC (Tables S13 and S14). This evidence concerns the gene KCNQ1 and breast cancer.